Decision: Favourable

Study Title:

PaTcH Trial: A phase 2 study to explore primary and emerging resistance mechanisms in patients with metastatic refractory Pancreatic cancer treated with Trametinib and

  • NREC Code:

    22-NREC-CT-011

  • Decision:

    Favourable

  • Meeting Date:

    26/01/2022

  • Study Type:

    CT application

  • Principal Investigator:

    Professor Austin Duffy

  • Sponsor:

    Cancer Trials Ireland

Scroll to Top
Skip to content